The Louisiana Supreme Court’s Alarming U-turn
The Pelican State deserves a judicial system that stands firmly on principles — not one swayed by the most recent political winds.
Janssen Pharmaceuticals v. A.Y.
(U.S., filed March 8, 2021): Urging the Court to address whether FDA regulations permit a manufacturer unilaterally to implement an off-label warning via a CBE or does the addition of an off-label warning require FDA approval.
Latest News
View all news
Trial Lawyers’ Latest Target: Life-Sustaining Baby Formula
Judges must recognize these cases for what they are: a cynical attempt to turn the suffering of families into a litigation jackpot.
Wall Street Journal: Junk Science Sometimes Still Prevails in Court
A recent Delaware case shows that not all states follow the Supreme Court’s 1993 Daubert ruling.
ATRA Applauds Utah AG Candidate Rudy Bautista for Signing Transparency Pledge
Republican Candidate Derek Brown Urged to Sign Pledge
Baltimore’s Opioid Lawsuit Is Wrong Approach to Overdose Crisis
Maryland taxpayers should be assured that state leadership is working in their best interests and not those of entrepreneurial trial lawyers.
ATRA Sounds Alarm on Colorado’s ‘Lawsuit Inferno’ in New Report
ATRA Declares State a ‘Lawsuit Inferno’ Amid Liability Onslaught